A Randomized, Double‐Blind, Double‐Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients

Ally, R., Schürmann, D., Kreisel, W., Carosi, G., Aguirrebengoa, K., Dupont, B., Hodges, M., Troke, P. +2 more·2001·Clinical Infectious Diseases

Cited by (331)

Items 201–300 of 331

  1. Pharmacological advances in the treatment of invasive candidiasis
    Daniel H. Deck, B. Joseph Guglielmo · 2006 · Expert Review of Anti-infective Therapy
  2. Influence of voriconazole and fluconazole on reconstituted multilayered oesophageal epithelium infected by Candida albicans
    J. Bernhardt, Hannelroe Bernhardt, Manfred Knoke, Kaja Ludwig · 2004 · Mycoses
  3. Nuevos antifúngicos: Las equinocandinas
    Alexis Diomedi P · 2004 · Revista chilena de infectología
  4. Therapeutic drug monitoring for antifungal triazoles: pharmacologic background and current status
    Andreas H. Groll, Silke Gastine · 2019 · Handbook of analytical separations
  5. Synthesis, Spectroscopic, Thermal and Catalytic Properties of Four New Metal (II) Complexes with Selected N- and O-Donor Ligands
    Agnieszka Czylkowska, Bartłomiej Rogalewicz, Anita Raducka, Natalia Błaszczyk, Tomasz P. Maniecki, Kinga Wieczorek, Paweł Mierczyński · 2020 · Materials
  6. Fungal Opportunistic Infections in HIV Disease
    Melody L. Duffalo · 2006 · Journal of Pharmacy Practice
  7. Antifungal Agents
    Rachel L Wattier, William J. Steinbach · 2017 · Elsevier eBooks
  8. The Role of Resistance in Candida Infections: Epidemiology and Treatment
    Jack D. Sobel, Robert A. Akins · 2017 · Springer eBooks
  9. Angio-oedema as an unusual tolerable side effect of voriconazole therapy
    Serap Gençer, Serdar Özer, Güler DEMİRHAN, Öznur Ak, Ayşe Alga Batırel · 2008 · Journal of Medical Microbiology
  10. Arzneimitteltherapie invasiver Candida- und Aspergillusinfektionen
    Georg Maschmeyer, Markus Ruhnke · 2002 · Der Internist
  11. Neue Arzneimittel
    Uwe Fricke, U. Schwabe · 2004 · Springer eBooks
  12. First Case of Identification of Candida kefyr and Pichia kluyveri in Lebanese Water
    Mohammad Hassan Halawi, Roudaina Nasser, Wissam Yassine, Hoda Yusef, Jamilah Borjac, Zaher Zeaiter · 2020 · Water Air & Soil Pollution
  13. Clinical Pharmacology of Itraconazole in Children and Adolescents
    Efi Drogouti, Zoi Dorothea Pana, Athanasios Tragiannidis, Georg Hempel, A. H. Groll · 2015 · Current Fungal Infection Reports
  14. Intervention médico-psychologique à Charm-el-Cheikh auprès des familles des victimes du crash aérien de la Flash Airlines
    Thierry Baubet, Jean-Michel Coq, Annick Ponseti-Gaillochon, Michèle Vitry, Christian Navarre, Didier Cremniter · 2006 · La Presse Médicale
  15. Management of Oropharyngeal and Esophageal Candidiasis in Patients with Hiv Infection
    Jose A Vazquez · 2010 · HIV Therapy
  16. Avances en el diagnóstico y tratamiento de las infecciones por levaduras: papel de los nuevos antifúngicos
    Javier Pemán, Benito Almirante · 2008 · Enfermedades Infecciosas y Microbiología Clínica
  17. Antifungal agents
    Shmuel Shoham, Andreas H. Groll, Thomas J. Walsh · 2010 · Elsevier eBooks
  18. Fungal Infections Among Patients with AIDS
    Olivier Lortholary, B. Dupont · 2010 · Springer eBooks
  19. Costo Efectividad de Posaconazol versus Fluconazol/Itraconazol en el Tratamiento Profiláctico de las Infecciones Fúngicas Invasivas en México
    Kely Rely, Pierre K. Alexandre, Guillermo Salinas Escudero · 2011 · Value in Health
  20. Fusariose em paciente imunocomprometido: sucesso terapêutico com voriconazol
    Thaís Pincelli, Hebert Roberto Clivati Brandt, Adriana Lopes Motta, Felipe Vieira Rodrigues Maciel, Paulo Ricardo Criado · 2008 · Anais Brasileiros de Dermatologia
  21. Anidulafungin: a novel echinocandin
    José A. Vázquez · 2005 · Therapy
  22. Evaluation of Febrile Neutropenia in Hematologic Malignancy Patients
    Müge Aslan, Yasemin Öz, Meltem Olga Akay, Filiz Akşit · 2014 · Mediterranean Journal of Infection Microbes and Antimicrobials
  23. Neue systemische Antimykotika: Wirkungsmechanismen, Interaktionen, unerwünschte Wirkungen
    Monika Schäfer‐Korting · 2003 · Mycoses
  24. Antifungal Agents and Antifungal Susceptibility Testing
    Sanjay G. Revankar, John R. Graybill, Thomas F. Patterson · 2010 · Wiley eBooks
  25. Embryotoxicity of fluconazole on developing chick embryos
    Rao Zahid Sattar, Asif Bilal, Sadia Bashir, Anisa Iftikhar, Irfan Yaqoob · 2024 · The Journal of Basic and Applied Zoology
  26. Novel Drug Delivery Systems for Antifungal Agents
    Jill Adler‐Moore, Richard T. Proffitt · 2004 · Springer eBooks
  27. Evaluation of Susceptibility to Fluconazole and Voriconazole in Oral Candida glabrata Isolates from Drug Addicts
    Narges Golirad, Leila Fozouni, Hamidreza Pordeli · 2019 · international journal high risk behaviors & addiction
  28. Clinical Recommendations of the Russian Gastroenterological Association on Diagnosis and Treatment of Infectious Esophagitis
    Vladimir T Ivashkin, Nikolay D. Yuschuk, Igor Veniaminovich Maev, А. С. Трухманов, Сторонова Ольга Андреевна, Anastasia A. Makushina, Sergey S. Pirogov, Oleg V. Zayratyants, Olga P. Alekseeva, Dmitry N. Andreyev et al. · 2020 · Russian Journal of Gastroenterology Hepatology Coloproctology
  29. Infektionen
    Andreas H. Groll, Arne Simon, Thomas Lehrnbecher · 2005 · Springer eBooks
  30. Progress in antifungal therapy: Echinocandins versus azoles
    Michael D. Nailor, Jack D. Sobel · 2006 · Drug Discovery Today Therapeutic Strategies
  31. 7 Candidiasis
    Jonathan D. Cartledge, A Freedman · 2011 · HIV Medicine
  32. Infectious Diseases in Pediatric Cancer
    Andrew Young Koh, Philip A. Pizzo · 2009 · Elsevier eBooks
  33. Mucocutaneous and Deeply Invasive Candidiasis
    Shmuel Shoham, Márcio Nucci, Thomas J. Walsh · 2011 · Elsevier eBooks
  34. Fungal infections in the patient with human immunodeficiency virus infection
    Michael Saccente · 2009 · Elsevier eBooks
  35. Infectious Esophagitis
    Vikneswaran Namasivayam, Joseph A. Murray · 2012 · Springer eBooks
  36. Brazilian guidelines for the management of candidiasis: a joint meeting report of three medical societies – Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia, Sociedade Brasileira de Medicina Tropical
    Arnaldo Lopes Colombo, Thaís Guimarães, Luís Fernando Aranha Camargo, Rosana Richtmann, Flávio Queiroz‐Telles, Mauro José Costa Salles, Clóvis Arns da Cunha, Maria Aparecida Shikanai‐Yasuda, Maria Luíza Moretti, Márcio Nucci · 2012 · The Brazilian Journal of Infectious Diseases
  37. Antifungal Agents
    William J. Steinbach, Christopher C. Dvorak · 2012 · Elsevier eBooks
  38. Echinocandins: Ask Not What They Can Do for Esophageal Candidiasis--Ask What Studies of Esophageal Candidiasis Can Do for Them
    Rabih O. Darouiche · 2004 · Clinical Infectious Diseases
  39. Knowledge Mapping of Aspergillus‐Related Research in Respiratory Medicine: A Bibliometric Analysis Based on English‐Language Articles Spanning 1975 to 2022
    Fan Jiang, Xuemei Li, Qing Qiao, Ge Zhang, Yanmei Zhang, Lin Su · 2024 · Canadian Respiratory Journal
  40. Voriconazole-Medicalneeds, Evidence, Potential for the Future
    宏美 白澤, Kenji Nagino · 2005 · Nippon Ishinkin Gakkai Zasshi
  41. Apport des nouveaux azolés dans la prise en charge des infections fongiques
    Michel Wolff, Lila Bouadma, Bruno Mourvillier · 2006 · Therapies
  42. Novel Antifungal Therapies
    Khaled H. Abu‐Elteen, Mawieh M. Hamad · 2007 · Springer eBooks
  43. Esophageal Candidiasis in Two Dogs With Megaesophagus: A Case Report
    Katie L. Anderson, Karen M. Tefft · 2025 · Journal of Veterinary Internal Medicine
  44. Antimicóticos de uso sistémico: ¿Con qué opciones terapéuticas contamos?
    Ana María Rivas González, Nora María Cardona-Castro · 2009 · Dialnet (Universidad de la Rioja)
  45. Synthesis, structural and theoretical studies, and biological evaluation of a nickel(II) complex derived from N4-tetradentate 1,2,4-triazole-derived ligand as potential anti-Alzheimer's agent
    Yevgen V. Herasymenko, Maxym O. Plutenko, Dmytro M. Khomenko, Md. Serajul Haque Faizi, Sergiu G. Shova, Irina A. Golenya, Rostyslav D. Lampeka, Igor O. Fritsky · 2024 · Journal of Molecular Structure
  46. The Role of Resistance in Candida Infections: Epidemiology and Treatment
    Jack D. Sobel, Robert A. Akins · 2009 · Humana Press eBooks
  47. Antifungal Therapy in Surgical ICU Patients
    Markus Alexander Weigand, Christoph Lichtenstern, B. W. Böttiger · 2007 · Springer eBooks
  48. Mycological Studies on the Sputa of HIV Positive Clients Attending HIV Clinic in Federal Medical Centre Owerri, Nigeria
    Mbata GC Ofondu EU · 2014 · Journal of AIDS & Clinical Research
  49. Les relations pharmacocinétique-pharmacodynamique des antifongiques. Conséquences pour le suivi thérapeutique
    Vincent Jullien, Olivier Lortholary · 2006 · Therapies
  50. New developments in antifungal strategy
    Anjali Shetty, Rosemary A. Barnes · 2004 · Expert Review of Anti-infective Therapy
  51. El papel de voriconazol en pacientes críticos con micosis invasoras
    Francisco Álvarez-Lerma · 2007 · Revista Iberoamericana de Micología
  52. Antifungal Therapy for Invasive Fungal Infections
    Hamid Badali, Sadegh Khodavaisy, Mehrnaz Mohammad Davoudi, E Biranvand, Masoud Mardani · 2014 · Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences
  53. Infections in Children With Cancer
    Monica I. Ardura, Andrew Young Koh · 2017 · Elsevier eBooks
  54. Human Fungal Pathogens and Drug Resistance Against Azole Drugs
    Preetida J. Bhetariya, Neha Sharma, Pragati Singh, Priyanka Tripathi, Santosh Kumar Upadhyay, Poonam Gautam · 2017 · Springer eBooks
  55. Candida in HIV infection
    William G. Powderly · 2012 · Elsevier eBooks
  56. Candida in HIV Infection
    Emma J. Devitt, William G. Powderly · 2008 · Elsevier eBooks
  57. Candidiasis
    Jack D. Sobel · 2007 · Humana Press eBooks
  58. Azoles in the Management of Systemic Fungal Infections
    David A. Stevens · 2004 · Infectious Diseases in Clinical Practice
  59. Systemic Antifungal Agents
    David A. Stevens · 2012 · Elsevier eBooks
  60. Azoles
    David R. Andes, William E. Dismukes · 2010 · Springer eBooks
  61. Reply
    Mark J. DiNubile, Carole A. Sable · 2002 · Clinical Infectious Diseases
  62. Transcriptional Regulation of Azole Antifungal Resistance and Tolerance in Candida Glabrata
    Kelly E. Caudle · 2010
  63. ▼Caspofungin and ▼voriconazole for fungal infections
    2004 · Drug and Therapeutics Bulletin
  64. Caspofungin versus Amphotericin B for the Treatment of Candidal Esophagitis
    Ángel Chocarro Martínez, A. Betancourt González, Isidra García García · 2002 · Clinical Infectious Diseases
  65. Current Status of Newer Antiinfectives
    Chand Wattal, Jaswinder Kaur Oberoi, Reena Raveendran, Kamaljeet Prasad · 2008 · Recent Patents on Anti-Infective Drug Discovery
  66. Infectious Esophagitis
    Salvatore Oliva, Sara Isoldi, Salvatore Cucchiara · 2021 · Springer eBooks
  67. Esophagitis
    PAUL S. GRAMAN · 2015 · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
  68. ANTIFUNGAL AGENTS
    Andreas H. Groll, Thomas J. Walsh · 2009 · Elsevier eBooks
  69. Antifungal Agents
    Debra J. Lugo, William J. Steinbach · 2022 · Elsevier eBooks
  70. Invasive fungal infections in children: advances and perspectives
    Andreas H. Groll, Julia R. Köhler, Thomas J. Walsh · 2007 · Birkhäuser Basel eBooks
  71. Infektionserkrankungen
    Ralf Bialek, Andreas H. Groll, Ulrich Heininger, Volker H. Schuster · 2007 · Elsevier eBooks
  72. Hallucinations auditives induites par le voriconazole : illustration par le monitorage plasmatique
    Emna Gaïes, Nadia Jebabli, Issam Salouage, S. Trabelsi, Rim Charfi, Mohamed Lakhal, Anis Klouz · 2011 · Journal de Mycologie Médicale
  73. Newer antifungal agents in pediatrics
    William J. Steinbach · 2019 · CRC Press eBooks
  74. Keratomykose engl. (Keratomycosis)
    W. Behrens‐Baumann · 2021 · Springer eBooks
  75. Voriconazole
    2015 · Elsevier eBooks
  76. Management of Resistant Candida Infections
    Sanya Clements, Christopher C. Kibbler · 2004 · Humana Press eBooks
  77. Utilisation, efficacy and safety of voriconazole: prospective, non-interventional study on treatment of IFIs in clinical practice
    Werner Heinz, Gerda Silling, Angelika Böhme · 2010 · Current Medical Research and Opinion
  78. Emergence of Candida albicans fungemia during voriconazole therapy
    I. Mohammédi, Anne Thiébaut, M. A. Piens, Laurent Argaud, O. Martin, Dominique Robert · 2004 · Journal of Infection
  79. Atemwegsinfektionen bei immunsupprimierten Personen
    Marcus Stockschläder, Michael Montemurro, Thomas Kiefer, Gottfried Dölken · 2003 · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
  80. Voriconazole
    2006 · Elsevier eBooks
  81. Voriconazole
    Dennis J. Cada, Terri L. Levien, Danial E. Baker · 2002 · Hospital Pharmacy
  82. Antifungal Therapy in Surgical ICU Patients
    Markus Alexander Weigand, Christoph Lichtenstern, B. W. Böttiger · 2006 · Yearbook of intensive care and emergency medicine
  83. Systemic Antifungals
    Fiona J. Cooke, Thomas Richard Rogers · 2005 · Springer eBooks
  84. Clinical Pharmacokinetics and Population Pharmacokinetic Analysis of Voriconazole in Transplant Patients
    Kelong Han · 2010 · D-Scholarship@Pitt (University of Pittsburgh)
  85. Satellite Symposia and Meet-the-Professor Sessions
    Schmid, Christoph, Schleuning, Michael, Kolb, Hans-Jochem · 2006 · Annals of Hematology
  86. Hallucinations secondaires au voriconazole chez un adolescent : pertinence du suivi pharmacocinétique
    Roxane Therrien, Antoine Robelet, Anne‐Laure Lapeyraque, Yves Théorêt, Maja Krajinović, Philippe Ovetchkine · 2013 · Pharmactuel
  87. Analyse de deux années d’utilisation compassionnelle du voriconazole à l’hôpital Saint-Louis (Paris)
    Emmanuelle Papy, Axel Carde, Patricia Ribaud, Pierre Faure, Sophie Touratier · 2006 · La Presse Médicale
  88. Pharmacotherapy of Invasive Fungal Infections with Voriconazole
    Beniam Ghebremedhin · 2011 · Clinical Medicine Reviews in Therapeutics
  89. Voriconazole: A Novel Antifungal
    Shana M. Gunderson, Rupali Jain, Larry H. Danziger · 2003 · Journal of Pharmacy Technology
  90. Nouvelles approches thérapeutiques des infections fongiques : place des nouvelles molécules
    Philippe Montravers, Vladimir Chterev, Pascal Augustin, L. Etchegoyen · 2008 · Antibiotiques
  91. Australasian guidelines for antifungal therapy in neonates and children with proven, probable and suspected invasive fungal infections
    CC Blyth, Christopher C. Blyth · 2007
  92. Antifungal Use for Opportunistic Infection in HIV Patients: Comparison of Efficacy and Safety
    Mei H E, Kok L Lai, Muhamad S Mohd Shariff, Nur A Mohd Razib, Zi K Sia, Tui H Wang, Sabariah Noor Harun · 2011
  93. Invasive Candidiasis in Management of Infections in Cancer Patients
    Matteo Bassetti, Małgorzata Mikulska, Juan Gea‐Banacloche, Claudio Viscoli · 2011 · Humana Press eBooks
  94. Epidemiology and prevalence of oral candidiasis in HIV patients from Chad
    Liliane Taverne-Ghadwal · 2016
  95. Antifungal Tedavide Yenilikler
    Ömrüm Uzun · 2003
  96. Pharmacokinetics of Voriconazole During Continuous Venovenous Hemofiltration
    Isabel Spriet, Joost Wauters, Ludo Willems · 2011 · Therapeutic Drug Monitoring
  97. Voriconazole (Vfend®) : une nouvelle arme contre les mycoses invasives Voriconazole : a new weapon against invasive fungal infections
    Mabel Aoun · 2004
  98. THÈSE POUR LE DIPLÔME D'ÉTAT DE
    Docteur En Médecine · 2007
  99. Candidiasis Treatment Should Pay Attention to the Immune Changing Patients
    Xiaoyang Yang, Mengjie Wan, Fangping Chen · 2016 · Open Journal of Internal Medicine
  100. Newer Antifungal Agents in Pediatrics
    Christina Henn, William J. Steinbach · 2009 · CRC Press eBooks